There is considerable excitement surrounding the treatment potential of T cell immunotherapies. Amongst these, CAR-T cells have demonstrated impressive therapeutic efficacy in a subset of ...
The partnership with PAR Systems further strengthens SORBA.ai’s global ecosystem of automation providers, system integrators, ...
The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...
As part of the EU-funded Clean Sky 2/Clean Aviation project “Large Passenger Aircraft” (“LPA”), the Fraunhofer-Gesellschaft in Stade, Germany, together with international project partners, has joined ...
Jeff Bezos is reportedly in early discussions to raise a $100 billion investment fund aimed at applying artificial ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...
MADRID, June 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported data highlighting its ...
End-to-end automation is a new wave of the industrial revolution. It is changing our understanding of manufacturing: from ...
Non-manufacturing sectors, those that don’t create physical goods, are experiencing a massive boom in automation, partly ...
In an industry where product quality increasingly determines competitive advantage, the ability to see what you're processing ...
Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results